NasdaqGS:TWSTBiotechs
Is Twist’s New High‑Quality Plasmid DNA Preps Business Altering The Investment Case For Twist Bioscience (TWST)?
Earlier this month, Twist Bioscience launched research-grade Plasmid DNA Preps offering animal origin-free and transfection-grade options with precise yield controls to support pharmaceutical and biotech customers’ preclinical studies.
By targeting stringent quality requirements such as endotoxin-free and animal origin-free DNA, Twist is positioning its platform as a specialized tool provider for nucleic acid therapeutics discovery and development.
We’ll now examine how this expansion into...